Morgan Stanley Hikes Labcorp (LH) Holdings Price Target to $283 Affirms ‘Overweight’ Rating
AbbVie (ABBV) Pipeline Bolstered as FDA Approves Mavyret Label Expansion for Hepatitis C
UBS Affirms Neutral Rating on Baxter International (BAX)
Goldman Sachs Raises Starbucks (SBUX) PT to $95, Turnaround Strategy Gains Clarity